Valuation: GC Corp.

Market Cap 467B 328M 285M 267M 244M 461M 31.28B 467M 3.12B 1.23B 15.63B 1.23B 1.21B 52.02B P/E 2024
33.4x
P/E 2025 -10.4x
Enterprise Value 1,861B 1.31B 1.14B 1.06B 973M 1.84B 125B 1.86B 12.44B 4.88B 62.28B 4.91B 4.81B 207B EV / Sales 2024
0.83x
EV / Sales 2025 0.86x
Free-Float
43.96%
Yield 2024
2.89%
Yield 2025 -
06-11 GC Corp.(KOSE:A005250) dropped from KOSPI 200 Index CI
05-27 Green Cross Holdings to divest 460 billion won worth of stake in Curevo RE
05-15 GC Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-31 Green Cross Holdings Corporation acquired 22.08% stake in GREEN CROSS WellBeing Corporation from GC Biopharma Corp. for KRW 50.5 billion. CI
03-18 GC Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-11 Green Cross Holdings Corporation announces Annual dividend, payable on April 17, 2026 CI
11-14 Green Cross Holdings Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
14/08/25 Green Cross Holdings Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
19/06/25 Green Cross Holdings Corporation agreed to acquire an additional 23.56% stake in GC Care for KRW 71.9 billion. CI
15/05/25 Green Cross Holdings Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
18/03/25 Green Cross Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2024 CI
14/11/24 Green Cross Holdings Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
06/11/24 China Resources Boya Bio-pharmaceutical Group Co.,Ltd completed the acquisition of 100% stake in Green Cross Hk Holdings Limited from Green Cross Holdings Corporation, Synaptic 1st Private Equity Fund and others for CNY 1.82 billion. CI
1 day+1.99%
1 week+13.50%
Current month+10.32%
1 month-1.16%
3 months-26.45%
6 months-32.63%
Current year-35.55%
1 week 8,820
Extreme 8820
10,310
1 month 8,630
Extreme 8630
10,380
Current year 8,630
Extreme 8630
18,010
1 year 8,630
Extreme 8630
18,010
3 years 8,630
Extreme 8630
18,490
5 years 8,630
Extreme 8630
35,100
10 years 8,630
Extreme 8630
56,300
Manager TitleAgeSince
Chief Executive Officer 52 01/03/2010
Chief Executive Officer 72 25/03/2010
Director of Finance/CFO 53 -
Director TitleAgeSince
Chairman 72 17/12/2010
Director/Board Member 76 01/03/2009
Director/Board Member 52 01/03/2010
Date Insider Type Main position Quantity % Market Cap.
4/25/25 A Buy

Chief Executive Officer

1,334 0.0028%
4/25/25 A Buy

Chief Executive Officer

3,191 0.0068%
4/25/25 A Buy

Chief Executive Officer

6,748 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
+1.99%+13.50%-34.02%-27.75% 322M
+1.89%-1.49%+55.62%+165.18% 1,043B
-0.24%-3.22%+50.51%+52.02% 621B
-0.95%-7.38%+22.83%+65.08% 435B
0.00%+0.83%+42.80%+37.60% 361B
+0.58%-3.51%+31.12%+40.54% 293B
-1.55%-9.78%+5.61%+8.62% 251B
-0.73%+4.44%+34.91%+66.41% 220B
-0.24%-13.15%-4.02%-44.69% 201B
-0.68%-1.41%+16.36%+66.32% 164B
Average +0.03%-2.40%+22.17%+42.93% 358.95B
Weighted average by Cap. +0.28%-3.79%+37.56%+77.18%

Financials

2024 2025
Net sales 2,205B 1.55B 1.35B 1.26B 1.15B 2.18B 148B 2.2B 14.74B 5.78B 73.78B 5.82B 5.69B 246B 2,451B 1.72B 1.5B 1.4B 1.28B 2.42B 164B 2.45B 16.38B 6.43B 82.03B 6.47B 6.33B 273B
Net income 24.03B 16.89M 14.66M 13.73M 12.56M 23.7M 1.61B 24.01M 161M 63.02M 804M 63.42M 62.04M 2.68B -69.51B -48.87M -42.41M -39.71M -36.33M -68.58M -4.66B -69.48M -465M -182M -2.33B -183M -180M -7.74B
Net Debt 1,042B 733M 636M 595M 545M 1.03B 69.79B 1.04B 6.96B 2.73B 34.87B 2.75B 2.69B 116B 1,394B 980M 851M 796M 729M 1.38B 93.36B 1.39B 9.32B 3.66B 46.65B 3.68B 3.6B 155B
Logo GC Corp.
Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Manufacturing and Sale segment mainly manufactures and sells blood products, general pharmaceuticals, vaccines and over-the-counter (OTC) drugs. The Medical Service and System Development and Supply segment primarily provides healthcare services. The Diagnostic and Analysis segment mainly engages in blood diagnostics and genetic analysis business. The Leasing and Service Business segment is primarily involved in the real estate leasing and the management of affiliated group companies. The Other segment mainly operates livestock operation and other business.
Employees
144
Date Price Change Volume
06/08/26 10,260.00 +1.99% 67,551
05/08/26 ₩10,060.00 +2.13% 81,644
04/08/26 ₩9,850.00 +4.90% 76,853
03/08/26 ₩9,390.00 +0.97% 55,097
31/07/26 ₩9,300.00 +2.09% 87,207
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A005250 Stock